BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5513339)

  • 1. [Clinical experiences with estro-gestagen combinations in the control of fertility].
    Guzmán P; Cudemus J; De Cudemus M; Trujillo H
    Rev Obstet Ginecol Venez; 1970; 30(3):371-83. PubMed ID: 5513339
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations].
    Osler M
    Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cutaneous complications of estro-progestative agents: statistical study. Apropos of 562 users].
    Dugois P; Amblard P; Manent J; Deshors G
    Ann Dermatol Syphiligr (Paris); 1971; 98(5):479-86. PubMed ID: 4259026
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arterial hypertension during treatment with estro-progestative agents].
    Dumont M; Pellissier B; Laforet J; Dick D
    J Med Lyon; 1971 Mar; 52(204):381-3. PubMed ID: 5135329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogens and progestagens. (Progress--utility, hazards--abuse)].
    Holzmann K
    Munch Med Wochenschr; 1972 Feb; 114(6):217-27. PubMed ID: 5067172
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gravidic cholestatic icterus, icterus due to estro-progestogen substances and incomplete anicteric sarcoidosic cholestasis].
    Mérillon H; Crespin B; Forest M; Saltiel H; Bricaire H; Laroche C
    Ann Med Interne (Paris); 1970; 121(8):711-6. PubMed ID: 5460165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal contraceptives].
    Martínez-Manautou J; Giner J
    Gac Med Mex; 1970 Oct; 100(10):993-1026. PubMed ID: 4943137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Choice of ovulation inhibitors].
    Mall-Haefeli M
    Ther Umsch; 1970 Oct; 27(10):652-9. PubMed ID: 5512723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of placebo instead of a pause in the taking of ovulation inhibitors].
    Hauser GA; Girotti M
    Ther Umsch; 1970 Oct; 27(10):666-70. PubMed ID: 5512725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception with estrogen and progestin combinations.
    Board JA
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):1-5. PubMed ID: 4992561
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical adverse effects and biochemical changes due to ovulation inhibitors].
    Clavadetscher P; Weber H
    Schweiz Med Wochenschr; 1973 Feb; 103(7):231-7. PubMed ID: 4686758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest].
    Figoureux J; Onghena G; Schlikker E; Wattiez M; Schlösser W; Vercautere E; William P
    Munch Med Wochenschr; 1967 Dec; 109(48):2555-8. PubMed ID: 5631905
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extragonadal endocrine repercussions of long-term estro-progestational treatment].
    Rozenbaum H; Netter A
    Actual Endocrinol (Paris); 1973; 13(0):73-8. PubMed ID: 4367475
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing oral contraceptives.
    Br Med J; 1969 Dec; 4(5686):789-91. PubMed ID: 5359946
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptive agents and the glucose tolerance problem.
    Cohn RE
    Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Chloasma" outside of gravidity. Studies on the clinical picture and causal significance of oral contraceptives and cosmetics].
    Ippen H; Tesche S
    Hautarzt; 1972 Jan; 23(1):21-5. PubMed ID: 5060958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contraceptives. Side effects and risks].
    García-Conti F
    Rev Colomb Obstet Ginecol; 1971; 22(6):393-407. PubMed ID: 4947668
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone excretion during and after prolonged treatment with ovulation-inhibiting estrogen-gestagen combinations].
    Haller J; König A
    Arch Gynakol; 1965; 202():242-5. PubMed ID: 5897097
    [No Abstract]   [Full Text] [Related]  

  • 19. [The mechanism of action of oral contraceptives].
    Manuilova IA
    Akush Ginekol (Mosk); 1971 Feb; 47(2):3-8. PubMed ID: 4940751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various possible adverse effects of synthetic estroprogestinic preparations at the extragenital level (review of the literature and personal contributions)].
    Lauro V
    Arch Ostet Ginecol; 1969; 74(3):193-235. PubMed ID: 5402696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.